Sector News

Univar Inc. appoints Kerry J. Preete as Independent Director

May 3, 2018
Chemical Value Chain

Univar Inc., a global chemical and ingredient distributor and provider of value-added services, announced that its board of directors has appointed Kerry J. Preete as an independent director, effective May 2, 2018.

Univar became a public company in 2015 and has increased the number of independent directors from two in 2015 to eight with this appointment.

“Kerry has a unique depth and breadth of international experience across a broad range of disciplines including distribution, product development, environmental stewardship, and mergers and acquisitions, which makes him well qualified to serve on our Board,” said Steve Newlin, chairman and chief executive officer. “His deep experience in the agricultural end market will be particularly valuable support for Univar’s growing agricultural business in the Americas, and his diverse business acumen, as well as his proven ability to provide executive leadership and new ideas across a wide range of markets, have made Kerry an advocate for strategic growth.”

Preete holds a bachelor of commerce degree from the University of Saskatchewan and a master’s of business administration from Washington University in St. Louis. Mr. Preete is executive vice president and chief strategy officer at Monsanto Company, where he has served for over 30 years in roles of increasing responsibility, including president of the global crop protection chemicals business and executive leader of the U.S. markets businesses. He currently serves on the board of directors of PolyOne Corporation and is a member of the compensation and nominating and corporate governance committees.

Source: Univar Inc.

Related News

February 28, 2021

Borealis to invest in new RTO to reduce CO2 emissions at Porvoo polyolefins plant

Chemical Value Chain

This equipment will significantly lower the site’s CO2 emissions, reduce flaring and save around 60 gigawatt hours (GWh) energy each year. Project kick-off is in February 2021, with completion planned for 2023.

February 28, 2021

Grace to acquire Albemarle’s fine chemistry business for $570 million

Chemical Value Chain

The acquisition significantly strengthens and expands Grace’s existing pharma portfolio. Pharma & Consumer is the largest, fastest growing and most profitable subsegment within Grace’s Materials Technologies business.

February 28, 2021

Solvay to carve out soda ash business

Chemical Value Chain

Solvay says it has decided to organize its soda ash and derivatives business into a separate and fully controlled legal structure.

Send this to a friend